EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

Daniel Cuervo-Zanatta, Hari Baskar Balasubramanian, Amir Pasokh, Marietta Zille iD

FEBS Letters · 07.08.2026

DOI: 10.1002/1873-3468.70412 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift FEBS Letters, online erschienen am 07.08.2026. Verfasst von Daniel Cuervo-Zanatta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Austria. Die Arbeit nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hochschuljubiläumsstiftung der Stadt Wien, Secretaría de Estado de Ciencia, Tecnología e Innovación, Österreichische Akademie der Wissenschaften.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age‐related decline in neurovascular integrity is an increasingly recognized contributor to cognitive impairment and neurodegenerative vulnerability. A central feature is blood–brain barrier (BBB) dysfunction arising from endothelial senescence, altered barrier regulation, and chronic low‐grade inflammation. In parallel, aging remodels the gut microbiota, with reduced diversity, loss of short‐chain fatty acid‐producing commensals, and expansion of pro‐inflammatory taxa. Converging evidence indicates that age‐related shifts in the gut microbiota alter microbiome function and can modulate BBB physiology through microbial metabolites, immune‐endothelial signaling, and systemic metabolic pathways. These data position the gut–brain axis as an important, but not sole, modulator of neurovascular aging. Preclinical and emerging human data suggest that dysbiosis lowers the threshold for BBB dysfunction, and microbiome‐targeted interventions in experimental models can improve barrier‐relevant features. Notably, no human trial has yet demonstrated that microbiome modulation prevents or reverses BBB impairment using validated neuroimaging or fluid biomarkers. This review synthesizes mechanisms of microbiota‐BBB crosstalk in aging, distinguishes correlation from causation, and outlines translational opportunities and limitations of dietary, probiotic, and fecal microbiota‐based strategies for preserving neurovascular health in older adults.

Schlagwörter

Stichwörter der Autor:innen

brainbrain endothelial cellsfibergut microbiotagut–brain axisinflammationsenescenceshort‐chain fatty acids

Autor:innen und Institutionen

  • Division of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Austria.
  • Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna, Austria.

ORCID-Profile: Marietta Zille

Förderung

  • Hochschuljubiläumsstiftung der Stadt Wien
  • Secretaría de Estado de Ciencia, Tecnología e Innovación
  • Österreichische Akademie der Wissenschaften

Zitieren

APA

Cuervo-Zanatta, D., Balasubramanian, H. B., Pasokh, A., & Zille, M. (2026). Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential. FEBS Letters. https://doi.org/10.1002/1873-3468.70412

Vancouver

Cuervo-Zanatta D, Balasubramanian HB, Pasokh A, Zille M. Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential. FEBS Letters. 2026. doi:10.1002/1873-3468.70412

BibTeX
@article{CuervoZanatta2026,
  author = {Cuervo-Zanatta, Daniel and Balasubramanian, Hari Baskar and Pasokh, Amir and Zille, Marietta},
  title = {Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential},
  journal = {FEBS Letters},
  year = {2026},
  doi = {10.1002/1873-3468.70412}
}
Kostenlos starten →